William Nikolic: How Homocysteine is Associated with Dementia
William Nikolic, Associate Director, MSL at Alfasigma USA, shared a post on LinkedIn about a recent article by A. David Smith et al., published in Journal of Alzheimer’s Disease, adding:
“An international consensus statement and several meta-analyses link hyperhomocysteinemia and age-related cognitive decline.
Based on the evidence, several researchers published an international consensus statement concluding:
‘There was consistent evidence that elevated homocysteine was one of the causes of age-related cognitive decline and dementia.’
Homocysteine sits at the intersection of methylation, vascular health, and neuronal function—making it a biomarker that deserves more attention in conversations about cognitive aging.”
Title: Homocysteine and Dementia: An International Consensus Statement
Authors: A. David Smith, Helga Refsum, Teodoro Bottiglieri, Michael Fenech, Babak Hooshmand, Andrew McCaddon, Joshua W. Miller, Irwin H. Rosenberg, Rima Obeid
Stay updated on all scientific advances with Hemostasis Today.
-
May 15, 2026, 04:00Danny Hsu: Join The THANZ Webinar on The Art and Science of Anticoagulation Stewardship
-
May 15, 2026, 03:48Deepak Yadav: What If the Way We Classify Stroke Tissue Is Too Simplistic for Modern Stroke Care?
-
May 15, 2026, 03:32Damon Race: Can Gene Therapy Deliver Durable Expression Over Time?
-
May 14, 2026, 17:17Abhijit D: Reticulocyte Count Methods in Hematology Laboratories
-
May 14, 2026, 16:46Michele Romoli: Neurointerventional Workforce Gaps and Stroke Thrombectomy Access in Europe
-
May 14, 2026, 16:37Reyes Calzada Bau: What It Means to Live with Immune Thrombocytopenia
-
May 14, 2026, 16:34Julia Owens: Improving Acute Stroke Care for Patients Without Timely Intervention
-
May 14, 2026, 16:28Krish Patel։ Opioid Overdose and Heart-Related Deaths in the USA (1999–2023)
-
May 14, 2026, 16:26Carla Goulart Peron: 79th World Health Assembly Momentum for Global Stroke Action